BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 81 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,956,000 | – | 78,385 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 110,447 | $2,679,000 | 2.17% |
| NEA Management Company, LLC | 3,449,845 | $83,693,000 | 1.88% |
| Boxer Capital, LLC | 2,014,858 | $48,880,000 | 1.66% |
| RA Capital Management | 2,589,904 | $62,831,000 | 0.95% |
| Tri Locum Partners LP | 142,911 | $3,467,000 | 0.86% |
| Artal Group S.A. | 1,646,517 | $39,945,000 | 0.71% |
| Bellevue Group AG | 2,243,000 | $54,415,000 | 0.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,047,599 | $25,415,000 | 0.53% |
| HighVista Strategies LLC | 26,770 | $649,000 | 0.48% |
| Avoro Capital Advisors LLC | 440,000 | $10,674,000 | 0.18% |